Example: Heart Attack

Clinical Trials on Lymphatic Filariasis

Total 83 results

NCT05868551

Not yet recruiting

Onchocerciasis-Associated Epilepsy, an Explorative Case-control Study

Epilepsy | Virus | Onchocercal Subcutaneous Nodule
NCT05678049

Not yet recruiting

Evaluation and Characterisation of Microplastics and Nanoplastics in Joint Synovial Liquid

Osteoarthritis, Knee | Knee Arthritis | Gout Arthritis | Microcrystal Disease
NCT05180461

Recruiting

Emodepside Phase II Trial for Treatment of Onchocerciasis

Onchocerciasis
NCT05084560

Not yet recruiting

Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug (AWOL)

Onchocerciasis | Filariasis, Lymphatic
NCT04913610

Recruiting

Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus Infection

Onchocerciasis
NCT04844905

Recruiting

Adjunctive Ivermectin Mass Drug Administration for Malaria Control (MATAMAL)

Lymphatic Filariasis | Scabies | Malaria,Falciparum | Strongyloidiasis | Neglected Tropical Diseases | Hook Worm | Soil Transmitted Helminths
NCT04311671

Recruiting

Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole

Onchocerciasis
NCT04124250

Recruiting

East New Britain Province Monitoring & Evaluation (ENBP M&E)

Lymphatic Filariasis Elimination by Mass Drug Administration | Monitoring and Evaluation of Mass Drug Administration for Lymphatic Filariasis | Acceptability of Mass Drug Administration for Lymphatic Filariasis
NCT04049851

Recruiting

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients (EOLoa)

Onchocerciasis, Ocular | Loiasis
NCT04035174

Not yet recruiting

Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa (EOLoa)

Diagnoses Disease | Onchocerciasis | Neglected Diseases | Loiasis
NCT03876262

Recruiting

Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis

Onchocerciasis
NCT03014167

Recruiting

Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)

Filariasis | Helminthiasis
NCT00001230

Recruiting

Host Response to Infection and Treatment in Filarial Diseases

Filariasis | Helminthiasis | Onchocerciasis | Mansonelliasis | Parasitic Infection
NCT04188301

Completed

Safety and Efficacy of IDA for Onchocerciasis (DOLF IDA/Oncho)

Onchocerciasis
NCT05750043

Completed

Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan (OAEMaridi)

Epilepsy | Onchocerciasis
NCT05749653

Completed

Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area (OAETanzania)

Epilepsy | Onchocerciasis
NCT04920292

Completed

PK, Safety and Tolerability of Single and Multiple Doses of Oxfendazole Tablets (HELP-OFZ)

Filariasis
NCT03962062

Completed

A Pharmacokinetic and Safety Study of Moxidectin to Identify an Optimal Dose for Treatment of Children 4 to 11 Years

Onchocerciasis
NCT00300768

Completed

Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection

Onchocerciasis
NCT04410406

Active, not recruiting

Moxidectin for LF, Cote d'Ivoire (DOLF)

Lymphatic Filariasis
NCT05085665

Completed

Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events

Loiasis
NCT03570814

Completed

Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin

Lymphatic Filariases | Trachoma
NCT02644525

Terminated

Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa

Loiasis
NCT02974049

Completed

Lymphatic Filariasis (LF) in Ivory Coast

Lymphatic Filariasis
NCT01905436

Completed

Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia (DOLF-LIBERIA)

Lymphatic Filariasis | Onchocerciasis | Soil Transmitted Helminth (STH) Infections
NCT01111305

Completed

Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis

Loiasis
NCT04049630

Completed

Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients (EOLoa)

Onchocerciasis, Ocular | Loiasis
NCT02929121

Completed

A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India (LeDoxy-India)

Lymphedema | Lymphatic Filariasis | Filariasis
NCT02927496

Completed

A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali (LeDoxy-Mali)

Lymphedema | Lymphatic Filariasis | Filariasis
NCT01547884

Completed

Effect of Filarial Infection on Immune Responses in Latent Tuberculosis

Mycobacterium Infections | Latent Tuberculosis | Tuberculosis | Filariasis
NCT02929134

Completed

A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka (LeDoxy-SL)

Lymphedema | Lymphatic Filariasis | Filariasis
NCT01939431

Terminated

Genetic and Other Aspects of Podoconiosis

Podoconiosis
NCT02899936

Completed

Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis

Lymphatic Filariasis
NCT03517462

Completed

Ocular Changes After Ivermectin - (DOLF IVM/Oncho)

Onchocerciasis
NCT03177993

Completed

Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji (FIT)

Scabies | Impetigo | Lymphatic Filariases | Soil Transmitted Helminths

Clinical Trials on Lymphatic Filariasis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations